SPDR DOW 30 ETF (DIA) News $DIA On Putin, Housing and

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
SPDR DOW 30 ETF (DIA) News $DIA

On Putin, Housing and the Fed - Ahead of Wall Street
Sheraz Mian - Zacks Investment Research - Tue Mar 18, 9:34AM CDT
Global markets were surprisingly reassured by Putin's comments that Russia favored the territorial integrity of Ukraine.

Should You Invest in the Dow Jones Today?
Anders Bylund, The Motley Fool - Motley Fool - Mon Mar 17, 1:00PM CDT
The stock market can help you build large savings stacks in the long run. Is the stock market good for you? Should you invest in something simple like the Dow Jones Industrial Average   today, or is it better to stick with dead-simple options such...

Is 2014 the Year of the Blue Chips?
Ted Cooper, The Motley Fool - Motley Fool - Sun Mar 16, 11:00AM CDT
The conventional wisdom holds that small capitalization stocks offer higher risk and higher return than large capitalization stocks. That pattern has held true in the five years since the post-recession market bottom in 2009; small capitalization...

Will the Uncertainty Last? - Ahead of Wall Street
Sheraz Mian - ZACKS - Fri Mar 14, 8:48AM CDT
Ukraine is likely a temporary worry, but the economic questions may have more staying power.

Don't Expect Copper to Bring Down U.S. Equities
at The Street - Fri Mar 14, 5:00AM CDT
As copper plummets, investors are becoming anxious. But Chinese economic weakness will not derail the U.S. equity rally.

Watch for DIAMONDS Trust Series I to Potentially Rebound After Falling 1.34% Yesterday
Comtex SmarTrend(R) - Thu Mar 13, 3:43PM CDT
DIAMONDS Trust Series I (AMEXIA) traded in a range yesterday that spanned from a low of $160.78 to a high of $164.03. Yesterday, the shares fell 1.3%, which took the trading range below the 3-day low of $162.47 on volume of 9.5 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

DIAMONDS Trust Series I Set to Possibly Rebound After Yesterday's Selloff of 1.34%
Comtex SmarTrend(R) - Thu Mar 13, 3:42PM CDT
DIAMONDS Trust Series I (AMEXIA) traded in a range yesterday that spanned from a low of $160.78 to a high of $164.03. Yesterday, the shares fell 1.3%, which took the trading range below the 3-day low of $162.47 on volume of 9.5 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

These 3 Stocks Might Be Great for Gambling, but They're Terrible Investments
Anders Bylund, The Motley Fool - Motley Fool - Thu Mar 13, 1:00PM CDT
Great investments can be risky. But that risk is always balanced by an outsized potential return, dampened by strong fundamentals, and ultimately defused by strong management with a vivid and long-term business plan. There's no such thing as a safe...

Traders Focus on Ukraine, Technicals
at The Street - Mon Mar 10, 7:12AM CDT
With little economic and corporate data this week, technical analysis may push markets higher.

Jim Cramer Quick Take: Beware of a Strong Unemployment Number
at The Street - Fri Mar 07, 11:51AM CST
Jim Cramer says the S&P 500 was already anticipating a good jobs number in its recent rally.

Quick Take: It May Take a Generation to Narrow Skills Gap
at The Street - Fri Mar 07, 11:00AM CST
Schulte, Roth & Zabel partner Ronald Richman said the evolution in technology allows companies to hire fewer employees.

Jim Cramer Quick Take: February Jobs Report Predictions Are All Over the Map
at The Street - Thu Mar 06, 12:36PM CST
Jim Cramer says he has never seen a range for the jobs report as wide as current prediction.

SmarTrend Watching for Potential Pullback in Shares of DIAMONDS Trust Series I After 1.33% Gain
Comtex SmarTrend(R) - Tue Mar 04, 4:17PM CST
DIAMONDS Trust Series I (AMEXIA) traded in a range yesterday that spanned from a low of $163.05 to a high of $164.00. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $163.77 on volume of 7.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Look for Shares of DIAMONDS Trust Series I to Potentially Pullback after Yesterday's 1.33% Rise
Comtex SmarTrend(R) - Tue Mar 04, 4:13PM CST
DIAMONDS Trust Series I (AMEXIA) traded in a range yesterday that spanned from a low of $163.05 to a high of $164.00. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $163.77 on volume of 7.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

[video] Quick Take: Stocks Get Defensive as Ukraine Crisis Intensifies
at The Street - Mon Mar 03, 1:00PM CST
The situation in Ukraine is intensifying. Ben Willis of Albert Fried says this pushed stocks even lower Monday.

Do ETFs Disrupt the Stock Market?
Dan Caplinger and Mike Klesta, The Motley Fool - Motley Fool - Fri Feb 28, 3:30PM CST
Exchange-traded funds have never been more popular. But some believe ETFs are distorting markets and causing disruptions to normal investing activity. Should investors fear ETFs and their influence? In the following segment from the Fool's video...

The Safer Way to Bet on More Dow Gains
Dan Caplinger, The Motley Fool - Motley Fool - Wed Feb 26, 3:30PM CST
For five straight years, the Dow Jones Industrials have posted substantial gains, recovering from the extensive damage that the 2008 recession and market meltdown did to the economy and the stock market. Yet, now that many investors have finally...

[video] Quick Take: The American Consumer, Strapped for Cash
at The Street - Tue Feb 25, 12:37PM CST
Cuttone & Co.'s Keith Bliss weighs in on the latest retail earnings, home construction numbers and how the latest spate of storms has been the noise in the numbers.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 24

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 18

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 21

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 34

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 26

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 27

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading

Top 5 Most Recently Viewed Articles

Boeing Aims to Raise $25 Billion Through Stock and Debt Sales

Updated Category News Views 83

Boeing's Strategic Move to Raise Funds Boeing recently filed a registration statement with U.S. market regulators to raise up to $25 billion through a mix of debt securities and stock offerings. This decision comes as the company aims to shore up its financial resources amid considerable debt maturities on the horizon. Financial Context for the Offering Though the...

Continue Reading
Novartis Achieves Strong Q2 Growth with Enhanced Guidance for 2025

Updated Category News Views 628

Impressive Q2 Financial Results from Novartis Novartis has recently shared its stellar performance for the second quarter, showcasing remarkable growth tantamount to an impressive 11% increase in net sales when accounting for constant currencies and a 12% increase in USD. Core operating income soared by 21%, reflecting a robust business framework and strategic focus on...

Continue Reading
Insightful Fireside Chat on Upexi's Future Strategies Ahead

Updated Category News Views 85

Upexi to Host Engaging Fireside Chat with Leadership Team Upexi, Inc. (NASDAQ: UPXI), a dynamic player in the consumer products and cryptocurrency sectors, has officially announced an upcoming fireside chat featuring its CEO, Allan Marshall, and Chief Strategy Officer, Brian Rudick. This event is set to take place on an upcoming Thursday at 11:00 a.m. ET, aiming to delve...

Continue Reading
Genius Group Faces Securities Law Violations Claims

Updated Category News Views 20

Another Day, Another Lawsuit: Genius Group's Legal Trouble Step right up, folks, it's time for the latest courtroom drama involving Genius Group Limited (NYSE American: GNS). You know the drill. A company gets too cocky, spouts off a bunch of bloated nonsense, and now they're knee-deep in securities law muck. This time it's Genius, and the folks at DJS Law Group are...

Continue Reading
Understanding Chart Industries' Stock Sentiment and Trends

Updated Category News Views 141

The Current Sentiment for Chart Industries Chart Industries, renowned for its innovation in energy and industrial gas solutions, has recently seen intriguing shifts in its stock dynamics. As of the latest report, the short percent of float for Chart Industries (GTLS) has notably decreased by 25.37%. This decline highlights that investors may be gaining confidence in the...

Continue Reading